Retrophin Inc.

Retrophin Inc.
Stock Exchange NASDAQ Stock Market
EPS
$3.07
Market Cap
$836.24 M
Shares Outstanding
41.44 M
Public Float
40.34 M

Profile

Address
3721 Valley Centre Drive
San Diego California 92130
United States
Employees -
Website http://www.retrophin.com
Updated 07/08/2019
Retrophin, Inc. is a biopharmaceutical company, which engages in identifying, developing, and delivering therapies to people living with rare diseases. Its products include Chenodal, Cholbam, and Thiola. The company was founded by Martin Shkreli on February 8, 2008 and is headquartered in San Diego, CA.

Financials

View All

Stephen J. Aselage
President, Chief Executive Officer & Director
Gary A. Lyons
Chairman